Bošković, J.; Dobričić, V.; Keta, O.; Korićanac, L.; Žakula, J.; Dinić, J.; Jovanović Stojanov, S.; Pavić, A.; Čudina, O.
Unveiling Anticancer Potential of COX-2 and 5-LOX Inhibitors: Cytotoxicity, Radiosensitization Potential and Antimigratory Activity against Colorectal and Pancreatic Carcinoma. Pharmaceutics 2024, 16, 826.
https://doi.org/10.3390/pharmaceutics16060826
AMA Style
Bošković J, Dobričić V, Keta O, Korićanac L, Žakula J, Dinić J, Jovanović Stojanov S, Pavić A, Čudina O.
Unveiling Anticancer Potential of COX-2 and 5-LOX Inhibitors: Cytotoxicity, Radiosensitization Potential and Antimigratory Activity against Colorectal and Pancreatic Carcinoma. Pharmaceutics. 2024; 16(6):826.
https://doi.org/10.3390/pharmaceutics16060826
Chicago/Turabian Style
Bošković, Jelena, Vladimir Dobričić, Otilija Keta, Lela Korićanac, Jelena Žakula, Jelena Dinić, Sofija Jovanović Stojanov, Aleksandar Pavić, and Olivera Čudina.
2024. "Unveiling Anticancer Potential of COX-2 and 5-LOX Inhibitors: Cytotoxicity, Radiosensitization Potential and Antimigratory Activity against Colorectal and Pancreatic Carcinoma" Pharmaceutics 16, no. 6: 826.
https://doi.org/10.3390/pharmaceutics16060826
APA Style
Bošković, J., Dobričić, V., Keta, O., Korićanac, L., Žakula, J., Dinić, J., Jovanović Stojanov, S., Pavić, A., & Čudina, O.
(2024). Unveiling Anticancer Potential of COX-2 and 5-LOX Inhibitors: Cytotoxicity, Radiosensitization Potential and Antimigratory Activity against Colorectal and Pancreatic Carcinoma. Pharmaceutics, 16(6), 826.
https://doi.org/10.3390/pharmaceutics16060826
